Ad
related to: Novavax
Search results
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 10 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) reports dismal results in second-quarter 2022. The stock dives in after-market...
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) has gone from being a relatively unknown healthcare company to being one of...
Novavax, Inc. (NASDAQ:NVAX) Shares Fly 54% But Investors Aren't Buying For Growth
Simply Wall St. via Yahoo Finance· 11 months agoNovavax, Inc. (NASDAQ:NVAX) shareholders are no doubt pleased to see that the share price has...
Is Novavax a Buy Now?
Motley Fool via Yahoo Finance· 4 weeks agoNovavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a...
Novavax (NVAX) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...
CDC recommends Novavax COVID vaccine after unanimous vote
CBS News via Yahoo News· 2 years agoA panel of the Centers for Disease Control and Prevention's outside vaccine advisers voted...
Is This a Good Sign for Novavax?
Motley Fool· 9 months agoNovavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. The biotech stock has been in the doldrums ever since the company...